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Abstract
Epidemics of respiratory syncytial virus (RSV) are known to occur in wintertime in temperate countries including the United
States, but there is a limited understanding of the importance of climatic drivers in determining the seasonality of RSV. In
the United States, RSV activity is highly spatially structured, with seasonal peaks beginning in Florida in November through
December and ending in the upper Midwest in February-March, and prolonged disease activity in the southeastern US.
Using data on both age-specific hospitalizations and laboratory reports of RSV in the US, and employing a combination of
statistical and mechanistic epidemic modeling, we examined the association between environmental variables and state-
specific measures of RSV seasonality. Temperature, vapor pressure, precipitation, and potential evapotranspiration (PET)
were significantly associated with the timing of RSV activity across states in univariate exploratory analyses. The amplitude
and timing of seasonality in the transmission rate was significantly correlated with seasonal fluctuations in PET, and
negatively correlated with mean vapor pressure, minimum temperature, and precipitation. States with low mean vapor
pressure and the largest seasonal variation in PET tended to experience biennial patterns of RSV activity, with alternating
years of ‘‘early-big’’ and ‘‘late-small’’ epidemics. Our model for the transmission dynamics of RSV was able to replicate these
biennial transitions at higher amplitudes of seasonality in the transmission rate. This successfully connects environmental
drivers to the epidemic dynamics of RSV; however, it does not fully explain why RSV activity begins in Florida, one of the
warmest states, when RSV is a winter-seasonal pathogen. Understanding and predicting the seasonality of RSV is essential in
determining the optimal timing of immunoprophylaxis.
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Introduction
Respiratory syncytial virus (RSV) is a major cause of severe
lower respiratory tract infections, including bronchiolitis and
pneumonia. Most children experience their first infection by age 2
years, but immunity is imperfect and infections continue to occur
throughout life, although subsequent infections tend to be less
severe. An estimated 66,000–199,000 deaths in children ,5 years
old are associated with RSV globally, the majority occurring in
developing countries [1]. In the United States (US), RSV remains
a major cause of severe respiratory infection in infants ,1 year of
age, and has been estimated to cause .2,000 hospitalizations per
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100,000 infants per year [2]. The incidence of RSV is strongly
seasonal in the US and other temperate countries, with the
majority of cases occurring during annual winter epidemics [3–8].
However, the timing of RSV activity varies substantially among
different regions of the US, with year-round circulation and peak
activity as early as October in southeastern Florida [9], and peaks
occurring as late as May in the upper Midwest [4,5,10].
The development of a safe and effective vaccine against RSV
has proven difficult. Therefore, prevention relies upon passive
immunoprophylaxis with palivizumab to reduce the number of
severe outcomes associated with RSV infection among high-risk
infants [11]. While palivizumab is effective at lessening the severity
of RSV infections in certain infants and children, the treatment is
very expensive and the protection afforded is short-lived, requiring
monthly injections during the RSV season; therefore, predicting
the timing of RSV activity is essential to optimizing the cost-
effectiveness of immunoprophylaxis [12–14].
Attempts have been made to correlate RSV seasonality with
climatic variables [13,15–25]. Such phenomenological analyses
are important; however, RSV epidemics show strong signatures of
nonlinear epidemic dynamics [26–29] and few studies have
explored climatic associations in a variety of locations covering a
range of RSV seasonality patterns and climatic regimes [25].
Therefore, we begin with linear models relating incidence patterns
and candidate environmental drivers of RSV epidemics in US
states. We then refine these to account for the dynamics of
infection and fluctuations in immunity and susceptibility that can
influence the relationship between environmental factors and
epidemic timing [29–33].
By combining statistical analyses with mathematical modeling of
the transmission dynamics of RSV across the US, we aimed to
gain a better understanding of the important drivers of the
spatiotemporal pattern of RSV epidemics. We build upon previous
efforts to model the transmission dynamics of RSV [26–30,34,35]
by fitting our model to data from a large number of states with
similar underlying socio-demographics, but markedly different
climatic conditions. By analyzing the relationship between
estimated seasonality parameters and climatic variables, we are
able to shed light on the environmental drivers of RSV
transmission.
Results
Description of spatiotemporal patterns of RSV
Hospitalizations for RSV were strongly seasonal, with annual
epidemics occurring during the winter months in most states
(Fig. 1A, S1 Fig.). Some states (e.g. Colorado, Iowa, California in
the 1990s) exhibited biennial patterns of alternating ‘‘early-big’’
epidemics in/around January of even-numbered years and ‘‘late-
small’’ epidemics in/around February of odd-numbered years.
The peak in RSV hospitalizations was notably earlier in Florida
(occurring in November/December) compared to the other states,
and hospitalizations occurred throughout the year (Fig. 1A). The
vast majority (.97%) of RSV-coded hospitalizations occurred
among children ,5 years of age, and ,75% occurred among
children ,1 year of age. The age distribution of cases varied
slightly by state (Fig. 1B).
Laboratory reports of RSV-positive specimens exhibited a
distinct spatial pattern, with mean timing of RSV activity (as
indicated by center of gravity, a measure of mean epidemic week
(S1 Text) [36]) occurring earliest in Florida and latest in Montana
(Fig. 1C). Again, some states exhibited a biennial pattern of RSV
epidemics; these states were highly concentrated in the upper
Midwest and West regions (Fig. 1D). The laboratory and
hospitalization data were highly correlated for those states with
both types of data available (r.0.71, p,0.0001, S1 Table).
Linking environmental drivers and timing of RSV activity
We explored trends between a variety of climatic and non-
climatic variables and timing of RSV activity across US states, as
measured by both center of gravity and phase difference with
Florida (Table 1 and S2 Table, S2 Fig.). Negative associations
were found with annual mean vapor pressure, temperature,
precipitation, and potential evapotranspiration (PET), and were
generally stronger when considering the mean value for the fall
months (September-November) for each climatic factor. Popula-
tion size and latitude were also associated with RSV timing
(Table 1). Fall vapor pressure had the highest explanatory power
(R2 = 72–76%), and was also the only significant factor in an
exploratory multivariate analysis (p,0.0001) (S3 Table). Note that
while these analyses may be indicative of statistical trends, they do
not account for the intrinsic nonlinear epidemic dynamics of RSV.
Dynamic modeling analyses
Mathematical modeling of the transmission dynamics of RSV
allows us to explore the mechanistic relationship between the
potentially important environmental variables and seasonal
variation in the transmission rate, via which the environmental
variables would likely act to affect the incidence of RSV [30]. We
developed an age-stratified SIRS (Susceptible-Infectious-Recov-
ered-Susceptible) model for the transmission dynamics of RSV,
accounting for repeat infections and using natural history
parameters derived from RSV cohort studies (Table 2). The
model was able to reproduce the age distribution (x2,0.17, p,
0.005) and seasonal pattern of RSV hospitalizations in ten states
(correlation between observed and predicted annual center of
gravity: r = 0.87, p,0.005) (Fig. 2, S1 Fig.). Notably, the model
was able to reproduce the biennial pattern of epidemics evident in
some states even though we assume that the transmission rate of
RSV follows the same seasonal pattern every year. Furthermore,
the model was able to replicate the transition from biennial
epidemics during the 1990s to annual epidemics during the 2000s
Author Summary
Respiratory syncytial virus (RSV) causes annual outbreaks
of respiratory disease every winter in temperate climates,
which can be severe particularly among infants. In the
United States, RSV activity begins each autumn in Florida
and appears to spread from the southeast to the
northwest. Using data on hospitalizations and laboratory
tests for RSV, we show that the timing of epidemics is
associated with a variety of climatic factors, including
temperature, vapor pressure, precipitation, and potential
evapotranspiration (PET). Furthermore, using a dynamic
model, we show that seasonal variation in the transmission
rate of RSV can be correlated with the amplitude and
timing of variation in PET, which is a measure of demand
for water from the atmosphere. States with colder, drier
weather and a large seasonal swing in PET tended to
experience an alternating pattern of ‘‘early-big’’ RSV
epidemics one year followed by a ‘‘late-small’’ epidemic
the next year, which our model was able to reproduce
based on the interaction between susceptible and
infectious individuals. However, we cannot fully explain
why epidemics begin in Florida. Being able to understand
and predict the timing of RSV activity is important for
optimizing the delivery of immunoprophylaxis to high-risk
individuals.
RSV Spatiotemporal Dynamics
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that occurred in California, possibly due to changes in the birth
rate.
From the best-fitting model to the aggregate data from the nine
states with complete age-stratified hospitalization time series from
1989–2009, we estimated the relative infectiousness of third and
subsequent infections compared to first two infections to be 0.51
(Table 2). The mean value of R0 was estimated to be 8.9, but we
observed state-specific variation in R0 (with estimated values
between 8.9 and 9.2), which was significantly correlated with
population density (r = 0.77, p,0.01) (S3 Fig.). The estimated
hospitalized fraction (h) also varied among states (from 3.2% in
California to 6.9% in Colorado), but was not significantly
correlated with population size or density, nor were estimates of
R0 and h significantly correlated with one another (S4 Table). Our
estimates of the hospitalized fraction are similar albeit slightly
lower than the 7–8% of infants with lower respiratory tract
infections who were hospitalized during cohort studies conducted
in the US and Kenya [37,38]; this is not surprising given one US-
based study noted that only 45% of RSV-positive inpatients
received an RSV-associated diagnosis [39].
The amplitude and timing of sinusoidal seasonal variation in
the transmission rate estimated by fitting the model to the
Fig. 1. Patterns of RSV activity across the United States for hospitalization and laboratory testing data. (A) Time series of weekly RSV
hospitalizations in select states. Raw hospitalization data is shown in blue, while the rescaled data accounting for the addition of an RSV-specific ICD-9
code in September 1996 is shown in green. (B) Age distribution of RSV hospitalizations across ten states. (C) Center of gravity of RSV activity in states
with at least ten consecutive years of laboratory reports. (D) Strength of biennial cycle in RSV activity, as indicated by the ratio of the biennial to
annual Fourier amplitude for laboratory report data.
doi:10.1371/journal.ppat.1004591.g001
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hospitalization data were both negatively correlated with mean
vapor pressure and mean precipitation (p,0.01), and positively
correlated with the amplitude and timing of PET in each state (p,
0.01) (Table 3). The seasonal offset parameter (illustrating timing
of peak transmissibility) was also significantly correlated with mean
minimum temperature (p,0.01). These parameter estimates were
also positively correlated (p,0.001) (S4 Table).
Fitting our model to the laboratory surveillance data for RSV
allowed for a more extensive analysis of the relationship between
state-specific climate indicators and the amplitude and timing of
seasonal variability in the transmission rate across a large number
of states with different climates. Since the laboratory data did not
contain the age of cases, we estimated R0 for each state based on
the observed relationship between R0 and population density prior
to fitting the model.
Again, we found significant negative correlations between the
amplitude and peak timing of RSV seasonal forcing (i.e.
seasonality in the transmission rate) and the mean vapor pressure,
minimum temperature, and precipitation across the 38 states (p,
0.0001) (Table 3, Fig. 3A-C), i.e. warmer, wetter states tended to
exhibit less seasonal variation and an earlier peak in the
transmission rate of RSV than cooler, drier states. We also found
a weaker but still significant positive correlation between the
amplitude of seasonal forcing and the amplitude of variation in
minimum temperature (p,0.005). Estimates for peak RSV
transmissibility, however, were not correlated with the timing of
the seasonal trough in minimum temperature or vapor pressure
(Table 3). A strong and significant positive correlation was
observed between both the amplitude and peak timing of RSV
seasonal forcing and the seasonal variation in PET (p,0.0001)
(Table 3, Fig. 3D). However, the state-to-state variability in the
timing of peak RSV transmissibility was more than twice the
observed variability in the timing of PET troughs (Fig. 3D).
The model was again able to capture the biennial pattern of
RSV epidemics apparent in some states. The correlation between
the observed and predicted ratio of the biennial to annual
periodicities, as estimated by Fourier analysis, was 0.89 (p,
0.0005). States with biennial RSV dynamics tended to have strong
seasonal forcing (b.0.25), which was associated with a large
amplitude of variation in PET and low minimum temperature,
Fig. 2. Transmission dynamic model for RSV and fit to age-specific hospitalization data. (A) Compartmental diagram illustrating the
structure of the model. White boxes represent infection states in the model, while grey boxes represent diseased/observed states (severe lower
respiratory disease, D, and observed cases, H). (B) Model fit to weekly RSV hospitalization data for California and Florida. The ICD9-CM coded
hospitalization data is shown in blue, the rescaled data is shown in green, and the fitted models are shown in red. (C) Age distribution of RSV
hospitalizations in California and Florida for hospitalization data and fitted models.
doi:10.1371/journal.ppat.1004591.g002
RSV Spatiotemporal Dynamics
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vapor pressure, and precipitation (Fig. 3). In general, the ratio of
the biennial to annual Fourier amplitude was slightly greater in the
data than predicted by the models; this is likely due to random
year-to-year variability in the size of RSV epidemics, which is not
accounted for in our deterministic models.
It was not possible to explain unusually high or low RSV activity
within a given state, apart from the regular biennial patterns,
based on any of the climatic variables. Deviations from model-
predicted patterns (observed minus predicted monthly RSV lab
reports) were not significantly correlated with temperature, vapor
pressure, precipitation, or PET (p.0.05) (S4 Fig.). Furthermore,
we were not able to explain year-to-year variation in epidemic
timing and size by directly parameterizing variation in the
transmission rate based on weekly variations in PET (S1 Text).
Such a model also provided a poor fit to the data, as indicated by
the log-likelihood (S5 Table).
Discussion
The spatiotemporal pattern of RSV activity in the United States
is in stark contrast to that of influenza [40] and rotavirus [36],
despite the fact that all are imperfectly immunizing infections that
exhibit strongly winter-seasonal epidemics. Using a combination of
exploratory statistical analyses and dynamic modeling approaches,
we set out to better understand geographical differences in RSV
seasonality and periodicities across the US and pinpoint mean-
ingful associations with climate. Identifying causal relationships
between climatic variables and RSV patterns could be used to
build predictive models of RSV incidence, which would help
inform guidelines for timing of immunoprophylaxis. Our results
indicate that climatological factors, particularly in vapor pressure,
minimum temperature, precipitation, and PET, are strong
candidates to explain the seasonal pattern of RSV epidemics in
the United States. States with low mean vapor pressure, minimum
temperature, and precipitation and large seasonal variation in
PET tended to exhibit a later peak in the timing of RSV
transmission and stronger seasonal forcing, potentially leading to
biennial epidemics.
Seasonal variation in PET was more tightly linked to seasonal
variability in the transmission rate of RSV compared to other
climate factors. Potential evapotranspiration is a measure of the
demand for water from the atmosphere, and tends to be highest
during the summer and lowest during the winter months (Fig. 4B
and S5 Fig.). RSV is transmitted via droplets and respiratory
secretions, and tends to be rapidly inactivated in small aerosols
[41]. Therefore, PET may be correlated with the drying time of
respiratory secretions and thus virus survival, but more research is
needed in this regard.
Impact of climatic drivers on RSV
A number of studies have examined the statistical association
between climatic factors and RSV seasonality. Most studies have
found a significant association between temperature and RSV
activity using time series correlation; however, the direction of the
association is not consistent across studies, and such studies do not
control for the temporal dependence among observations. RSV
activity tends to occur in the coldest months in temperate regions
where winter outbreaks are common [6,13,18–20,22,42] and in
the warmest months in subtropical and tropical climates [16,25].
Low absolute humidity (proportional to vapor pressure) has been
found to be an important correlate of RSV activity in Spain [20].
Yusuf et al. [25] also observed significant correlations between dew
point (a measure of absolute humidity) and RSV activity across
nine cities worldwide, but again the association was negative in
temperate locations and positive in subtropical locales. Paynter
et al. [30] used a mathematical model to show that seasonality in
the transmission rate of RSV followed a similar pattern to rainfall
in the Philippines. Accordingly, the peak in RSV activity coincides
with the rainy season in a number of tropical locations [15,43]. It
may be that both colder temperatures and rain cause people to
Table 2. Transmission dynamic model parameters.
Parameter description Symbol Parameter value Source
Duration of maternal immunity 1/v 16 weeks [65]
Duration of infectiousness
First infection 1/c1 10 days [71,72]
Second infection 1/c2 7 days
Subsequent infection 1/c3 5 days
Relative risk of infection following
First infection s1 0.76 [37,66–68]
Second infection s2 0.6
Third infection s3 0.4
Proportion of infections leading to lower respiratory tract infection
First infection, ,6 months old dp,0 0.5 [37,66,69]
6–11 months old dp,0.5 0.3
1–2 years old dp,1 0.2
$2 years old dp,2 0.1
Second infection ds,a = 0.75*dp,a
Relative infectiousness
Second infections r1 0.75 [37,66,69]
Subsequent infections r2 0.51 Estimated
doi:10.1371/journal.ppat.1004591.t002
RSV Spatiotemporal Dynamics
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aggregate indoors, thereby facilitating RSV transmission [6,44].
More studies are needed to tease apart the associations between
climate, human behavior, and infectious disease transmission.
Interestingly, our study is the first to explore the association
between PET and RSV dynamics.
Our US analysis indicates that mean vapor pressure, minimum
temperature, precipitation, and seasonal variation in PET are
good candidates to explain the timing of RSV activity across
different states in the US. However, states with higher minimum
fall temperature and vapor pressure tend to experience earlier
RSV activity, which is difficult to reconcile with the broad seasonal
patterns of this pathogen, which predominates in winter in
temperate regions. Furthermore, the estimated seasonal offset
parameters (i.e. timing of peak transmission) did not correspond
well with the timing of the seasonal trough in temperature and
vapor pressure across states. In contrast, the association between
RSV and PET is more consistent, as states with lower seasonal
variation in PET, lower average PET, and earlier wintertime PET
troughs tend to experience earlier and less strongly seasonal RSV
epidemics (Florida being the most extreme example). However, as
most climatic variables are typically highly correlated, it is difficult
to pinpoint a single driver of RSV dynamics with great certainty.
Climate variables may be a proxy for something else that affects
transmission, or there may be a more complex relationship
between climate and RSV transmission (e.g. non-linear or
threshold effects). Furthermore, most climatic conditions (includ-
ing PET) will vary between indoor and outdoor environments.
Additional analyses using similar methodological approaches in
different geographic settings and at different geographic scales
may be able to further disentangle the effect of various climatic
factors.
It is possible that the influence of climatic factors on RSV
seasonality may be modulated by other important factors that
affect the RSV transmission. Demographic factors such as
population density and crowding indices have been shown to be
associated with the length of the RSV season across different parts
of Colorado [45]. Birth rates have been shown to be an important
driver of the spatiotemporal pattern of rotavirus epidemics in the
United States [36], but do not appear to be correlated with the
timing of RSV epidemics. Changes in the birth rate in California
(which tended to be larger than within other states) may help to
explain why epidemics in this state transitioned from biennial
Table 3. Correlation coefficients between climatic variables and estimated seasonality parameters in RSV transmission model.
Hospitalization data Laboratory data
Climatic variable Amplitude of seasonality (b) Seasonal offset (Q) Amplitude of seasonality (b) Seasonal offset (Q)
Vapor pressure
Mean 20.832* 20.942*** 20.788*** 20.862***
Amplitude 20.511 20.600 20.307 20.437*
Offset 0.404 0.085 20.341 20.112
Minimum temperature
Mean 20.575 20.801* 20.760*** 20.782***
Amplitude 0.253 0.201 0.469* 0.404
Offset 20.114 20.431 20.341 20.119
Precipitation
Mean 20.844* 20.774* 20.760*** 20.733***
Amplitude 20.305 20.201 20.036 0.066
Offset 20.090 20.313 0.213 0.092
Potential evapotranspiration
Mean 0.212 20.030 20.104 20.184
Amplitude 0.810* 0.699 0.689*** 0.671***
Offset 0.802* 0.930** 0.611*** 0.787***
Wet days
Mean 20.537 20.361 20.487* 20.256
Amplitude 20.527 20.236 20.053 0.074
Offset 0.033 20.112 20.088 20.279
Cloud cover
Mean 20.388 20.134 20.091 20.006
Amplitude 0.385 0.479 0.470* 0.588**
Offset 20.824* 20.812* 20.554** 20.755***
Diurnal temperature range
Mean 20.388 20.134 0.522** 0.355
Amplitude 0.084 0.284 0.574** 0.493*
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during the 1990s to annual during the 2000s; however, more work
is needed to understand how variation in birth rates and
transmission rates may impact RSV dynamics. Increased contact
rates among older siblings during school terms have also been
hypothesized to play an important role in determining RSV
seasonality [13,46], and have been shown to play in important role
for other respiratory infections [47–49]. However, we found that
incorporating school-term forcing did not improve the fit of our
model to the data (S1 Text, S6 Table). By modeling the
transmission dynamics of RSV, we are able to account for how
these factors may interact with other sources of seasonal forcing,
such as climatic factors, while controlling for the temporal
dependence in the data.
Relationship to previous mathematical models for RSV
Our findings are similar to those of other dynamic models of
RSV. White et al. [27] and Weber et al. [29] found that the
estimated amplitude of seasonal forcing was generally greater for
temperate locations and could explain the biennial pattern of RSV
epidemics in Turku, Finland. These biennial epidemic patterns, in
particular, cannot be explained by statistical associations alone;
they result from the dynamic feedback that occurs when an annual
seasonal forcing leads to an ‘‘overshooting’’ of the susceptible
population in the big epidemic years, leaving fewer susceptible
individuals who can be infected the following year. We build on
these previous analyses by fitting our model to a large number of
states with different climates. As such, we are able to correlate
differences in the estimated seasonal forcing parameters for various
states to climatological differences. Our estimates of the amplitude
of seasonal forcing are greater than those of the best-fit model of
White et al. [27], but similar to those of Weber et al. for Florida
and sites that exhibit biennial epidemics (e.g. Montana and
Finland) [29].
Fitting our model to the age-specific hospitalization data gave us
more power to estimate R0 compared to previous dynamic models,
which were fit to data aggregated across age groups. Our estimates
of R0 = 8.9–9.2 were similar to those obtained by White et al.
(2007) for their best-fitting model, and were slightly higher than
those obtained by Weber et al. (2001) for a similar model structure.
Any discrepancies can likely be explained by differences in
parameter assumptions. For example, unlike Weber et al. (2001),
we assume a decrease in the duration of infectiousness and severity
of repeated infections. This relatively high value of R0 suggests that
controlling RSV transmission will require substantial effort.
Climate change, in particular an increase in average annual
temperature, has been hypothesized to be responsible for
shortening the RSV season in England [17]. However, a shift
towards earlier RSV epidemics has also been observed in São
Paulo, Brazil, which cannot be attributed to changes in climate
[13]. A similar shift towards later epidemics has been noted
elsewhere [45]. We also observed some changes in the timing of
RSV activity in the US, mostly towards earlier RSV activity, but
these patterns do not appear to be linked to climate trends (S7
Table).
Caveats and future directions
An important limitation of our analyses is that we did not have
data on the genetic strains of RSV causing cases over time and
Fig. 3. Relationship between estimated seasonality parameters for model fit to laboratory report data and select climatic factors.
The estimated amplitude of seasonal forcing in RSV transmission (top) and the estimated seasonal offset parameter (bottom: Q = 0 represents January
1 and Q = 20.2 represents October 19) is plotted against (A) annual mean vapor pressure (hecta-Pascals), (B) annual mean minimum temperature (uC),
(C) annual mean precipitation (mm/month), and (D) amplitude (relative to the annual mean) and timing of trough in potential evapotranspiration
(PET; 0 = January 1, 0.1 = February 6). The colorbar on the right indicates the ratio of the biennial to annual Fourier amplitude for the observed data
(outer circle) and fitted model (inner diamond). Select states are labeled: Arizona (AZ), Florida (FL), Georgia (GA), Hawaii (HI), Louisiana (LA), Montana
(MT), New York (NY), South Dakota (SD), Texas (TX), Wyoming (WY).
doi:10.1371/journal.ppat.1004591.g003
RSV Spatiotemporal Dynamics
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among different states. Therefore, we did not explicitly model the
interaction of RSV types A and B, which White et al. (2005) found
could help explain differences in the transmission dynamics of
RSV in England and Wales and Turku, Finland. It is possible that
strain cycling may help to explain between-year deviations from
model-predicted epidemic patterns, for which we did not find any
correlation with climatic factors (S4 Fig.). However, the interaction
among different subtypes of RSV is unlikely to be the main driver
of differences in the seasonality and periodicity of RSV activity
among different states. In cities with biennial RSV activity, a single
subtype has been observed to predominate for two years (i.e.
through both an early-big and late-small season) prior to being
replaced by the other subtype [50–52]. Furthermore, no
association was observed between subtype predominance and
epidemic severity and timing over 15 years in one US city [53].
Another limitation is that we assumed age-specific population
mixing patterns were equivalent to those in the Netherlands [54],
since no such broadly based studies have been conducted in the
United States. Population mixing patterns were broadly similar
across a variety of European countries [55], and are likely to be
similar in the United States. However, the Netherlands appears to
have slightly higher contact rates among 0–4 year olds compared
to other countries such as the United Kingdom [54,56]. This may
have influenced our estimates of R0, as well as limited the potential
impact of school-term forcing in helping to explain the spatio-
temporal pattern (S1 Text). Similar studies of population mixing,
and how such patterns vary seasonally, should be conducted in the
United States. Also, the lack of age detail in the laboratory report
data limited our ability to directly estimate R0 for all states
included in the analysis.
Finally, our epidemiological datasets were prone to changes in
reporting and coding practices, and these datasets captured only a
fraction of all RSV infections. We elected to use very specific RSV
outcomes to have an accurate picture of the age distribution of
RSV cases, and addressed sensitivity issues by rescaling the data to
remove time trends and incorporating an estimated reporting rate
in our transmission model. Importantly, sensitivity analyses
indicate that our results are robust to the rescaling method and
that RSV-specific hospital admissions align well with broader
outcomes such as bronchiolitis (S8 Table, S6–S7 Fig.).
One potential hypothesis that follows from this study, which
may help to explain why RSV activity in the US begins in Florida
(particularly southeastern Florida [9]), is that less variable climatic
conditions in Florida combined with high population density in
cities such as Miami allows for year-round persistence of RSV. In
contrast, other states may experience routine fadeouts of RSV
infection during the summer months. If this were the case, then
peak RSV activity in Florida could begin as soon as climatic
conditions (and population mixing) favored a slight increase in
transmissibility of the virus, whereas other states may be
dependent on outside introduction of the virus once the effective
reproductive number (Re = R0 x the proportion susceptible) is
greater than 1. Indeed, White et al. (2007) observed frequent
fadeouts of infection in a stochastic version of their best-fitting
model, particularly in temperate settings. The role of fadeouts in
the spatiotemporal dynamics of RSV could be explored using a
stochastic metapopulation model informed by local rather than
state-aggregate data, which is an important direction for future
research. The availability of detailed data and large variability in
climate make the United States a very useful test case for this.
Further, it would be interesting to compare the results with
Europe, where strain typing has also been performed. Finally, a
more detailed understanding of the spatial transmission of this
disease could be obtained by fitting phylogeographic models to
large-scale viral sequencing data [57]. Such models were
instrumental in elucidating the migration patterns of the
influenza virus over the past decade [58], but require a large
amount of well-sampled molecular data, which are not yet
available for RSV.
We have been able to demonstrate that mean vapor pressure,
temperature, and precipitation as well as seasonal fluctuations in
PET are correlated with seasonal variation in the transmission rate
of RSV; these factors could help to explain differences in the
strength of RSV seasonality across the different regions of the
United States. Stronger seasonal forcing can also drive the
occurrence of biennial patterns of RSV activity. However, the
rationale behind why RSV epidemics tend to begin in the
southeastern United States remains elusive. Our analysis highlights
the role of potential evapotranspiration as a previously unidenti-
fied correlate of RSV transmission. A better understanding of the
relationship between PET and RSV survival may help predict the
timing of RSV activity across the United States and further guide
the optimal timing of prophylaxis. More importantly, a more
detailed mechanistic understanding of RSV transmission dynamics
will be crucial to help predict the impact of RSV vaccination
programs, as vaccine candidates are currently undergoing clinical
trials.
Fig. 4. Monthly patterns of RSV activity and potential
evapotranspiration. (A) The mean number of RSV hospitalizations
per 100,000 total population per month for select states, beginning in
July. (B) The monthly mean potential evapotranspiration (mm/day) is
plotted for each state.
doi:10.1371/journal.ppat.1004591.g004
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Materials and Methods
Data sources
We examined the spatiotemporal pattern of RSV activity in the
United States using two sources of weekly epidemiological data: (1)
age-specific hospitalizations with any mention of RSV from ten
State Inpatient Databases (SIDs) of the Healthcare Cost and
Utilization Project (HCUP), from January 1989 to December 2009
for nine states (Arizona, California, Colorado, Iowa, Massachu-
setts, Maryland, New Jersey, Washington, and Wisconsin) and
from 1989–1996 and 2005–2009 for Florida, and (2) laboratory
reporting of the number of RSV-positive tests (by any detection
method) from the National Respiratory and Enteric Virus
Surveillance System (NREVSS), for which 38 states had at least
10 consecutive years of consistent data between July 1989 and
May 2010.
Hospitalization data. Age-specific data on hospitalizations
for RSV were obtained from the State Inpatient Databases (SIDs)
of the Healthcare Cost and Utilization Project (HCUP) main-
tained by the Agency for Healthcare Research and Quality
(AHRQ) through an active collaboration with AHRQ. All hospital
discharge records from community hospitals in participating states
are included in the database. HCUP databases bring together the
data collections efforts of State data organizations, hospital
associations, private data organizations, and the Federal govern-
ment to create a national information resource of encounter-level
health care data [59]. We extracted all hospitalization records that
included the International Classification of Diseases 9th revision,
Clinical Modification (ICD-9-CM) code for RSV (079.6, 466.11,
480.1) in any position among up to 15 discharge diagnoses that
were consistently available. We extracted data on the age of the
patient (in 1-year age categories from 0–4 years old and 5-year age
categories from 5–9 years to $95 years old), week and year of
admission, and hospital state. We also extracted data on
hospitalizations for bronchiolitis (ICD-9-CM 466.1) for compar-
ison, but focused our analysis on the RSV-specific hospitalization
data; for the purposes of fitting models to the seasonal pattern and
age distribution of RSV cases, the specificity of the diagnosis is
more important than the sensitivity.
We limited our analysis to the nine states that had data available
from January 1, 1989 to December 31, 2009: Arizona, California,
Colorado, Iowa, Massachusetts, Maryland, New Jersey, Washing-
ton, and Wisconsin. We also included Florida in our analysis
because of its unusual seasonal pattern, even though data was not
available from 1997–2004.
The RSV-specific ICD-9 code for acute bronchiolitis [466.11]
was introduced in September 1996, leading to a large increase in
RSV-coded hospitalizations (Fig. 1). To account for this change,
we calculated a correction factor for each state equal to the mean
number of RSV hospitalizations per week from 1997 to 2009 over
the mean number of weekly RSV hospitalizations from 1989 to
1995. We then multiplied the pre-September 1996 hospitalization
time series by the state-specific correction factor. Since we had
limited data for Florida, we multiplied the pre-September 1996
hospitalization data by the mean under-reporting factor for the
other nine states. The adjusted number of RSV-specific hospital-
izations was similar to the rate of bronchiolitis hospitalizations in
children ,5 years old before and after September 1996 (S5 Fig.).
Laboratory reporting of RSV. Data on laboratory reporting
of RSV tests by state (including the District of Columbia) from July
1989 to May 2010 were obtained from NREVSS. A map and list
of current participating laboratories can be found on the NREVSS
website (http://www.cdc.gov/surveillance/nrevss/labs/default.
html). We included RSV detections by all three diagnostic
methods collected in NREVSS: antigen detection, reverse
transcription polymerase chain reaction (RT-PCR) and viral
culture. While the use of these different diagnostic methods has
varied over time, so long as they do not vary seasonally (and in
different ways in different states), this variation in testing methods
should not bias our analysis. We limited our analysis to states with
at least 10 consecutive years of consistent reporting (defined as $
100 RSV tests, $10 RSV-positive samples, and ,15 consecutive
weeks in which no laboratories reported results to NREVSS
annually). The resulting dataset consisted of 38 states; the total
number of RSV-positive samples by state ranged from 587
(District of Columbia) to 65,232 (Texas).
We rescaled the laboratory data on the number of RSV-positive
tests to account for changes in testing practices over time. First, we
calculated a two-year moving average of the weekly number of
RSV tests (both positive and negative specimen results) in each
state. We then calculated a weekly scaling factor equal to the
average number of RSV tests for the state during the entire period
of consistent reporting divided by the two-year moving average (S6
Fig.). The rescaled number of RSV-positive tests was then
estimated to be the reported number of positive tests times the
scaling factor (S6 Fig.). We estimate a ‘‘reporting fraction’’ (h)
when fitting the dynamic model to the laboratory data (see
‘‘Dynamic model description’’ below); hence, we do not need to
know the exact level of reporting so long as it is consistent through
time.
In some states, there may have been changes in the geographic
distribution of laboratories that report to NREVSS over time. This
could have affected the spatiotemporal pattern of epidemics
observed within that state, e.g. if there was greater (or less)
representation of rural areas over time, which may have slightly
different timing of RSV activity than urban centers. However,
since we are fitting our model to capture the average timing of
epidemics over time (for at least 10 years), the impact on our
conclusions regarding the overall spatiotemporal pattern of RSV
activity across states should be minimal.
Demographic data. The initial population size for each state
was obtained from the 1990 US census data [60]. We assumed the
birth rate varied between states and over time, according to data
on the crude annual birth rate for each state from 1990 to 2009
[61]. Individuals were assumed to age exponentially into the next
age class, with the rate of aging equal to 1/(width of the age class).
We divided the ,1 year age class into 12-month age groups to
more accurately capture aging among this important age class (in
which .70% of cases occur). The remaining population was
divided into 6 classes: 1–4 years old, 5–9 years, 10–19 years, 20–39
years, 40–59-years, and 60+ years old. We assumed deaths
occurred from the last age class and adjusted the net rate of
immigration/emigration and death from other age groups in order
to produce a rate of population growth and age structure similar to
that of the US.
Climate data. Monthly climatic data were obtained from
worldwide climate maps generated by the interpolation of climatic
information from ground-based meteorological stations with a
monthly temporal resolution and 0.5u latitude by 0.5u longitude
spatial resolution (update CRU TS 3.0 0.5u, available from http://
badc.nerc.ac.uk/view/badc.nerc.ac.uk__ATOM__dataent_12562
23773328276) [62]. The climatic variables used were precipita-
tion, monthly average of daily minimum and maximum temper-
atures, average temperature, diurnal temperature range, potential
evapotranspiration (PET), average number of wet days (days with
.1 mm of rain), cloud cover, and vapor pressure. These monthly
climatic variables were extracted from the pixels with more than
10,000 inhabitants, within each US state for the period from 1994
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to 2004. Weekly time series were derived from the monthly data
using linear interpolation. Climatic information was extracted and
checked for consistency using scripts written in MATLAB version
7.5.0 (MathWorks, Natick, MA) specifically for this purpose.
As a sensitivity analysis, we also extracted daily data for all
weather indicators from the National Oceanic and Atmospheric
Administration’s North American Regional Reanalysis (http://
www.esrl.noaa.gov/psd/data/gridded/data.narr.html). We only
considered the 30 by 30 km pixel corresponding to the census-
determined population center of each state, and aggregated daily
data at the weekly level from January 1, 1989 to December 31,
2010. Despite the different temporal and geographic resolution
and data sources, the two datasets were highly correlated
(r = 0.95–0.99 for temperature and PET, r.0.75 for all other
indicators), and the results of our analyses remained qualitatively
the same (S2 Table and S8 Table).
Exploratory analyses of putative environmental drivers
Summary measures describing the seasonal variation in
temperature, PET, and vapor pressure, including the mean value,
relative amplitude of seasonal fluctuations, and seasonal offset,
were derived by fitting harmonic curves to the climatic time series
(S5 Fig.). We also calculated mean monthly and weekly values for
all climatic variables in each state, and used these to estimate
deviations from the average state-specific climatology.
We obtained two complementary measures of RSV epidemic
timing, based on the center of gravity (mean epidemic week, where
each week is weighted by the number of cases—S1 Text, [36]) and
phase decomposition obtained from wavelet analysis [40,63]. In
the wavelet analysis, we used the 0.8–1.2 year periodicity band
from the wavelet spectrum to extract weekly phases, and
calculated the difference between phase in Florida, where RSV
epidemics are earliest, and phases in the other states, averaged
throughout the study period.
Following earlier work [36,64], we estimated the statistical
association between empirical seasonal patterns of RSV and
climate factors using univariate and stepwise multivariate regres-
sion models, with RSV timing as the outcome (center of gravity or
phase difference with Florida), and climate variables as predictors.
Monthly climate predictors were summarized as annual and
seasonal means; since fall (September-November) climate values
were most strongly associated with RSV, we do not report
regression results for the other seasons here. We also considered
demographic (birth rate, population size and density), geographic
(latitude, longitude), and sampling (number of RSV tests) factors in
multivariate regression models. Finally, time trends in climate and
RSV seasonal characteristics were assessed by linear regression
using year as a potential predictor.
Dynamic model description
We developed an age-structured SIRS model to describe the
transmission dynamics of RSV (Fig. 2A). The model assumes
individuals are born with protective maternal immunity (M),
which wanes exponentially (with a mean duration of 3–4 months)
[65], leaving the infant susceptible to infection (Sn, where n is the
number of previous infections). Following infection with RSV,
individuals develop partial immunity, which reduces the rate of
subsequent infection and the duration and relative infectiousness
of such infections, consistent with epidemiological studies and
previous models of RSV transmission [26,27,29]. We assume a
progressive build-up of immunity following one, two, and three or
more previous infections (In) [37,66–68]. Both age and number of
previous infections were assumed to influence the risk of
developing severe lower respiratory disease (D) possibly requiring
hospitalization [37,66,69]. We parameterized the model based on
data from cohort studies conducted in the US and Kenya
(Table 2) [37,38,66–72]. Transmission-relevant contact patterns
were assumed to be frequency-dependent and were parameterized
based on self-reported data on the number and age of
conversational partners from one European study [54,55]; no
such study has been conducted among a widely representative
cohort in the US.
We initially fit our model to the age-stratified hospitalization
data from all nine states with complete data from 1989–2009 in
order to estimate the mean transmission rate, relative infectious-
ness of first and second versus subsequent infections, seasonality
parameters, and reporting fraction (i.e. proportion of individuals
with severe lower respiratory tract disease who are hospitalized,
coded as RSV, and reported in our dataset), which are key
unknown parameters. We then fixed the relative infectiousness and
fit the model to the hospitalization data from each of the nine
states plus Florida individually, using the other estimated
parameters from the cumulative data fit as our starting conditions
to estimate state-specific transmission rates, seasonality parame-
ters, and reporting fractions. For each fit, we seeded the model
with one infectious individual in each age group and used a burn-
in period of 40 or 41 years, examining the fit using both even- and
odd-year burn-in periods to allow for the biennial pattern of
epidemics present in some states, and selected the best-fitting
model for each state. We also explored longer burn-in periods and
examined the model output to ensure that the equilibrium quasi-
steady state had been reached.
Seasonality in the instantaneous rate of transmission of RSV
was modeled using sinusoidal seasonal forcing with a period of 1
year (52.18 weeks) as follows: b(t)~b0 1zbcos(2p(t{w))ð Þ, where
b0 is the baseline transmission rate, b is the amplitude of
seasonality, and Q is a seasonal offset parameter (a measure of
timing of peak transmissibility), and t is the time (in years) [31,32].
We constrained Q to be between 20.5 and 0.5, where Q = 0
represents January 1 and Q = 20.5 and Q = 0.5 both represent July
1. These parameters were estimated by fitting our model to the
state-specific data.
We used maximum likelihood to determine the best-fitting
models. For each set of parameters, the likelihood of the data given
the model was calculated by assuming the number of hospitaliza-
tions in each age class (a) during each week (w), xa,w, was Poisson-
distributed with a mean equal to the model-predicted number of
severe lower respiratory tract infections due to RSV (Da,w) times
the reporting (or hospitalized) fraction (h), x̂a,w~hDa,w, as has
been described previously [27,36]. The log-likelihood (log(L)) of











While this observation model may fail to capture the true
variability in the distribution of cases, other observation models
(e.g. negative binomial) would require estimating an additional
parameter, which we do not feel is justified. We used the
‘‘fminsearch’’ command in MATLAB v7.14 (MathWorks, Natick,
MA) to minimize the –log(L), which employs a direct simplex
search method.
Next, we fit the model to the laboratory data on RSV-positive
tests from 38 states. The laboratory data did not contain detail on
the age of cases; therefore, we could not derive reliable estimates of
the baseline transmission rate by fitting our model to these data,
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since estimates of the baseline transmission rate and reporting
fraction are inherently confounded. (The age distribution of cases,
pattern of epidemics, and mean incidence rate inform estimates of
the baseline transmission rate, while the mean incidence also
informs estimates of the reporting fraction.) Instead, we estimated
the baseline transmission rate for each state from the relationship
we observed between population density and R0 among the ten
states with hospitalization data (S3 Fig.). We fixed the R0 for the
District of Columbia at the maximum observed R0 (for New
Jersey). We then estimated the amplitude of seasonality, seasonal
offset parameter, and reporting fraction by fitting our model to the
rescaled laboratory data. We examined the sensitivity of our results
to the method we used to correct for changes in testing and
reporting effort for RSV over time by also fitting our model to the
raw number of RSV-positive tests reported, instead applying the
estimated scaling factor to the model output (i.e. dividing the
model output by the scaling factor for each week). The log-
likelihoods of the fitted models were similar (S5 Table), and the
results were qualitatively the same (S8 Table).
We examined the correlation between the estimated model
parameters for each state and the significant climatic variables
from the univariate statistical analyses. We calculated the
Pearson’s correlation coefficient and associated p-value for each
state-specific parameter estimate and climatic variable of interest.
We also examined the ability of the model to capture the biennial
pattern of RSV epidemics present in some states by comparing the
strength of the biennial cycle in the observed and predicted RSV
time series. The strength of the biennial cycle was calculated as the
ratio of the biennial to annual Fourier amplitude [73,74]. Finally,
we examined whether monthly deviations from average climatic
conditions could help explain the difference between observed and
predicted monthly RSV activity across states.
Supporting Information
S1 Fig. Fit of transmission dynamic model for RSV to
age-specific hospitalization data. The rescaled weekly
hospitalization data (accounting for the change in reporting
practices that occurred in September 1996) is shown in blue, while
the fitted models are shown in red. Age distributions of RSV
hospitalizations among children ,5 years of age are also shown for
the data and fitted models.
(EPS)
S2 Fig. Plots of weighted univariate regression models
of RSV timing against key climatic predictors, where
weights are defined as 1/variance in timing estimates.
Timing is based on the center of gravity in RSV activity in weekly
laboratory-surveillance reports in 50 states and DC (blue dots),
averaged over 21 epidemics 1989–2010 (vertical red bars represent
variance). Climate variables are averaged over the fall period for
(A) vapor pressure (hecta-Pascals), (B) minimum temperature (uC),
and (C) potential evapotranspiration (mm/day). Blue lines
represent predicted values and shaded areas represent 95% CI.
See Table 1 for parameter estimates.
(TIF)
S3 Fig. Relationship between the basic reproductive
number and population density. The value of R0 estimated
by fitting the transmission dynamic model to the age-specific
hospitalization data is plotted against the population density for
each state. The dots are color-coded according to the mean center
of gravity of RSV activity in each state, as indicated by the color bar.
(EPS)
S4 Fig. Analysis of transmission model residuals.
Deviations from model-predicted patterns (observed minus
predicted monthly lab reports for October to April) for 38 states
versus (A) monthly minimum temperature minus average state-
specific minimum temperature for that month, (B) monthly vapor
pressure minus average vapor pressure, (C) monthly precipitation
minus average precipitation, and (D) monthly potential evapo-
transpiration minus average potential evapotranspiration at lags
of 0 and 1 month between the case time series and the climate
time series.
(EPS)
S5 Fig. Seasonal variation in climatic variables. Average
monthly values for the years 1994 to 2004 (solid lines) and sine
curves fitted to the monthly averages (dotted lines) are plotted for
each of the climate variables for select states.
(EPS)
S6 Fig. Comparison of data on weekly hospitalizations
for RSV and acute bronchiolitis. (A) The adjusted number
hospitalizations for RSV (ICD-9-CM 079.6, 466.11, 480.1) per
week in California (blue) is plotted along with the number of
hospitalizations for acute bronchiolitis (ICD-9-CM 466.1) for
all age groups (pink) and for children ,5 years old (light blue).
(B) The age distribution of patients ,5 years old hospitalized
with a diagnosis of RSV (blue) or acute bronchiolitis (light
blue). (C) The age distribution of patients of all ages
hospitalized with a diagnosis of RSV (blue) or acute bronchi-
olitis (pink).
(EPS)
S7 Fig. Rescaling of laboratory data to account for
changes in RSV reporting over time. (A) The number of
weekly RSV-positive tests for South Dakota (left) and Florida
(right) for the entire period from July 1989 to June 2010 (cyan)
and the period with consistent reporting (defined as $100 RSV
tests/year, $10 RSV-positive samples/year, and ,15 consec-
utive weeks/year in which no laboratories reported results to
NREVSS) (blue). (B) The total number of tests for RSV
(positive and negative) by week (blue), along with the 2-year
moving average number of tests for each week (red) and mean
number of tests per week across the entire period with
consistent reporting (green). (C) Rescaled number of RSV-
positive tests, where the scaling factor is equal to the mean
number of tests over the entire period with consistent reporting
(green line in B) divided by the weekly moving average number
of tests (red line in B). The rescaled number of weekly RSV
hospitalizations for Florida are plotted in grey (on the right axis)
for comparison.
(EPS)
S1 Table Correlation between RSV hospitalizations and
laboratory reports (rescaled number of RSV-positive
specimens) for states with both types of data.
(DOCX)
S2 Table Sensitivity analysis on climate variables:
univariate regression of timing of RSV activity against
climatic indicators derived from weekly data. (Same as
Table 1 but using weekly climatic data for the population center of
each state from the NOAA/NARR reanalysis dataset.) Separate
models are built for phase timing (average weekly phase difference
with Florida, the earliest RSV state) and center of gravity
(weighted average of RSV epidemic week, where each week is
weighted by the number of RSV cases). All epidemic measures are
based on weekly laboratory-reported RSV time series. Results are
provided for climate indicators summarized annually or during the
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fall period. Boldface indicates significance (p,0.05) in the
exploratory analysis. As in Table 1, specific humidity (also known
as vapor pressure) and temperature and are the strongest
univariate predictors of RSV timing. Stepwise multivariate
regression consistently indicates that specific humidity is the
strongest predictor of RSV timing, consistent with S3 Table.
(DOCX)
S3 Table Stepwise multivariate regression of RSV
timing in 50 US states and District of Columbia. Two
indicators of timing are considered as outcome: phase extracted
from the 1-year component of reconstructed wavelet decomposi-
tion (average weekly phase difference with Florida; see methods)
and center of gravity (see earlier description in supplement). The
potential explanatory variables are listed in Table 1. p-value for
entry,0.20; p-value for remaining in model ,0.05.
(DOCX)
S4 Table Correlation among estimated parameters for
the transmission dynamic model.
(DOCX)
S5 Table Comparison of baseline transmission dynam-
ic model to model with the transmission rate directly
proportional to PET. Log-likelihood of model fit to the
laboratory report data from 38 states using sinusoidal seasonal
forcing versus modeling the transmission rate as directly
proportional to weekly variations in PET.
(DOCX)
S6 Table Comparison of baseline transmission dynam-
ic model to model including school-term forcing. Log-
likelihood of transmission dynamic model fit to hospitalization
data from 10 states using sinusoidal seasonal forcing alone versus
including both school-term and sinusoidal seasonal forcing of the
transmission rate.
(DOCX)
S7 Table Time trends in climate variables for the 50 US
states plus District of Columbia, 1994-2004 based on the
monthly CRU climate dataset. Only states with significant
trends (p,0.05) are listed.
(DOCX)
S8 Table Sensitivity of correlation between seasonality
parameters and climatic variables to method of rescal-
ing laboratory data and resolution of climate data.
Correlation coefficients between estimated seasonality parameters
of model fit to laboratory data with scaling factor applied to model
output and sine curves fit to the monthly (CRU) and weekly
(NOAA) climate data.
(DOCX)
S1 Text Supplementary methods.
(PDF)
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